Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Tag
  • C-His
    (1)
  • Tag Free
    (1)
TargetMol | Tags By Expression System
  • HEK293 Cells
    (1)
TargetMol | Tags By Species
  • Human
    (1)
TargetMol | Tags By SPR-compatible Buffer
  • Buffer exchange required
    (1)
  • Ready-to-use
    (1)
Filter
Search Result
Results for "

haemostatic

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    5
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Natural Products
    3
    TargetMol | Natural_Products
  • Recombinant Protein
    2
    TargetMol | Recombinant_Protein
TargetMolTargetMolCompare
Annexin V/ANXA5 Protein, FITC conjugated
annexin A5
TMPY-00540
The placental anticoagulant protein Annexin A5 (ANXA5) is a multifunctional protein that is highly expressed on the apical surfaces of syncytiotrophoblasts, and plays an important role in haemostatic regulations, maintaining blood fluidity of the placenta. Annexin A5 (ANXA5) is a protein abundantly expressed in normal placenta where it contributes to the healthy outcome of a pregnancy. Lower ANXA5 levels have been observed in M2 ANXA5 haplotype carrying chorion. The association found between the maternal carriage of the M2 ANXA5 haplotype and an elevated risk of IUGR and or PE supports the hypothesis that carrier status of this haplotype and the consequently reduced placental ANXA5 expression might be responsible, at least partially, for the onset of these gestational vascular complications. ANXA5 could be used as a biomarker for the early detection of PE and for the prediction of its severity. ANXA5 as an embryonic anticoagulant that appears deficient in contiguous specter of thrombophilia-related pregnancy complications culminating more frequently in miscarriage in a maternal M2 carrier background. As a potential indicator for malignancy and lymphatic metastasis, ANXA5 overexpression increases in vitro migration and invasion of Hca-P cell, promotes in vivo malignancy, LNM rate and level of Hca-P-transplanted mice. Hereditary thrombophilias can impair vascular placental functions and predispose to the birth of small-for-gestational age (SGA) babies. The placental anticoagulant protein annexin A5 (ANXA5) may contribute to this process. A functional haplotype (M2) within the ANXA5 gene is associated with fetal loss and venous thrombosis.
  • Inquiry Price
7-10 days
Size
QTY
TargetMolTargetMolCompare
Coagulation factor VII/F7 Protein, Human, Recombinant (His)
SPCA, coagulation factor VII (serum prothrombin conversion accelerator), Coagulation factor VII, Coagulation factor 7
TMPY-02014
Expression system: HEK293 Cells
Length: 1-444, Full length
Activity: Not Tested
  • Inquiry Price
7-10 days
Size
QTY
SPR-compatible buffer